Curcumin Hình ảnh
87 hình ảnh từ nghiên cứu có bình duyệt
A network pharmacology approach to identify the mechanisms and molecular targets of …
A network pharmacology approach to identify the mechanisms and molecular targets of …
A network pharmacology approach to identify the mechanisms and molecular targets of …
A network pharmacology approach to identify the mechanisms and molecular targets of …
A network pharmacology approach to identify the mechanisms and molecular targets of …
Figure 6. (A) Targets of curcumin significantly related Aβ, tau, or Aβ and tau. (B) PPI networks of targets of curcumin-related Aβ and tau pathology. (C) The top 10 core …
A network pharmacology approach to identify the mechanisms and molecular targets of …
Figure 7. (A–E) Differential gene expression compared to the control group in the temporal cortex (F–H) Differential gene expression compared to the control group in the entorhinal cortex. (F–H) Differential …
A network pharmacology approach to identify the mechanisms and molecular targets of …
Figure 8. (A–E) The ROC curve of targets of curcumin against AD-related tau and aβ pathology. AD = Alzheimer disease, ROC = receiver operating characteristic.
A network pharmacology approach to identify the mechanisms and molecular targets of …
Figure 9. Molecular docking analysis of curcumin, green dashed lines represents hydrogen bond and its length. (A) Molecular docking of curcumin with CSF1R. (B) Molecular docking of curcumin with AR. …
A network pharmacology approach to identify the mechanisms and molecular targets of …
Curcumin-Loaded Gelatin Nanoparticles Cross the Blood-Brain Barrier to Treat Ischemic Stroke by …
Curcumin-Loaded Gelatin Nanoparticles Cross the Blood-Brain Barrier to Treat Ischemic Stroke by …
Curcumin-Loaded Gelatin Nanoparticles Cross the Blood-Brain Barrier to Treat Ischemic Stroke by …
Curcumin-Loaded Gelatin Nanoparticles Cross the Blood-Brain Barrier to Treat Ischemic Stroke by …
Figure 3 (A) Viability of SH-SY5Y cells treated with varying amounts of Cur@Gel NPs and Cur@GAR NPs in CCK-8 assay. (B) Pictures of live-dead cell staining and crystal violet staining …
Curcumin-Loaded Gelatin Nanoparticles Cross the Blood-Brain Barrier to Treat Ischemic Stroke by …
Figure 4 (A) Schematic diagram and movement trajectories of experimental rats of the open field test and (B) the swimming test. (C) Number of squares, (D) exercise duration and (E) …
Curcumin-Loaded Gelatin Nanoparticles Cross the Blood-Brain Barrier to Treat Ischemic Stroke by …
Figure 5 (A) H&E staining images of brain tissue sections from experimental rats on day 7 after surgery. (B) Immunofluorescence staining images of CASP-3, GFAP, IBA-1, and MPO in brain …
Curcumin-Loaded Gelatin Nanoparticles Cross the Blood-Brain Barrier to Treat Ischemic Stroke by …
Figure 6 Elisa assay for (A) CASP-3, (B) CD4, (C) CD11b, (D) FOXP3, (E) sCD86 and (F) MRC1 in brain tissues of experimental rats at 7 days post-surgery. (G) H&E …
Curcumin-Loaded Gelatin Nanoparticles Cross the Blood-Brain Barrier to Treat Ischemic Stroke by …
Scheme 1. (A) Scheme of the fabrication of DHCNPs. (B) DHCNPs exhibited neuroinflammation tropism to injured spinal cord after intravenous injection. (C) The neuroinflammatory and SCI modulation process of the …
A biomimic anti-neuroinflammatory nanoplatform for active neutrophil extracellular traps targeting and spinal …
A biomimic anti-neuroinflammatory nanoplatform for active neutrophil extracellular traps targeting and spinal …
A biomimic anti-neuroinflammatory nanoplatform for active neutrophil extracellular traps targeting and spinal …
A biomimic anti-neuroinflammatory nanoplatform for active neutrophil extracellular traps targeting and spinal …
A biomimic anti-neuroinflammatory nanoplatform for active neutrophil extracellular traps targeting and spinal …
A biomimic anti-neuroinflammatory nanoplatform for active neutrophil extracellular traps targeting and spinal …
A biomimic anti-neuroinflammatory nanoplatform for active neutrophil extracellular traps targeting and spinal …
Trang 2 / 4